Peter Jackson
Executive Director at Infex Therapeutics
False
Advertisement
A Call to Arms for Antimicrobial Resistance
August 3, 2023
Investment into new antimicrobial therapies has been lacking for decades – and now we’re now paying the price. We don’t have enough drugs to fight the superbugs.
13 min read
Newsletters
Receive the latest pharmaceutical news, personalities, education, and career development – weekly to your inbox.
